Status: current, Primitive. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 174331011000036114 | Mycobacterium bovis BCG Tice strain | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 174332011000036115 | Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) Tice strain) (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mycobacterium bovis BCG Tice strain | Is a | medicinal substance | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Oncotice BCG 500 million CFU powder for injection, 500 million CFU vial | has intended active ingredient | True | Mycobacterium bovis BCG Tice strain | Inferred relationship | Some | 1834476732 |
| Mycobacterium bovis BCG Tice strain | has intended active ingredient | True | Mycobacterium bovis BCG Tice strain | Inferred relationship | Some | 1 |
| Mycobacterium bovis BCG Tice strain 500 million CFU injection, vial | has intended active ingredient | True | Mycobacterium bovis BCG Tice strain | Inferred relationship | Some | 1001276554 |
| Mycobacterium bovis BCG Tice strain 500 million CFU injection, vial | has Australian BoSS | True | Mycobacterium bovis BCG Tice strain | Inferred relationship | Some | 1001276554 |
| Oncotice BCG 500 million CFU powder for injection, 500 million CFU vial | has Australian BoSS | True | Mycobacterium bovis BCG Tice strain | Inferred relationship | Some | 1834476732 |
This concept is not in any reference sets
FHIR